buoyantintelligence
  • 01Overview
  • 02Portfolio
  • 03Company Atlas
    • Buoyant book
    • All listed companies
  • 04Screener & valuation
  • 05House view
  • 06Markets
  • 07India top-down
  • 08Investors
  • 09Library & data
Release
August 2026 · rev 1
Opportunities PMS · Published
As at 31 Aug 2026 · IST₹ · ₹ cr · BSE 500 TRI
Present
Internal working platform. Published figures are extracted from the August 2026 source package and reviewed; reference prices and fundamentals are unlicensed working data, not for redistribution. Past performance is not indicative of future returns.
All listed companies/Dr. Agarwal's Health Care Limited
03 /Listed universe · Healthcare · Hospitals

Dr. Agarwal's Health Care Limited.

Value itCompareScreener.in ↗Tijori ↗NSE ↗BSE ↗
Snapshot

Healthcare · Hospitals

Dr. Agarwal's Health Care Limited engages in running, owning, and managing eye care hospitals, opticals, pharmacies, etc. and related services in India and internationally. It offers femto cataracts, lenticular procedure, retinal surgeries, anterior segment reconstruction, and corneal transplants, as well as refractive and other surgeries. The company also develops, designs, manufactures, imports, and exports healthcare devices, which include ophthalmic diagnostic devices, such as auto perimeter, optical biometers, and ophthalmoscopes. In addition, the company offers consultations, diagnoses, and non-surgical treatments; and sells opticals, contact lenses and accessories, and eye care related pharmaceutical products. Dr. Agarwal's Health Care Limited was incorporated in 2010 and is based in Chennai, India.

Market cap
₹15,642 cr
P/E (TTM)
105.1
P/B (latest)
7.7
ROE (TTM)
6.6%
ROCE (TTM)
10%
Sales CAGR 3y
26.9%
PAT CAGR 3y
12.3%
Debt / equity
0.08x
Promoter
32.3%
Dividend yield
—
Size
Micro
Codes
AGARWALEYE · 544350
Price

₹491.2 · 29 Sept 2026

1M
−3.3%
3M
+3.6%
6M
+19.9%
YTD
−1.8%
1Y
−1.5%
3Y
—
5Y
—
vs 52w high
−12.4%

52-week ₹406.55 – ₹560.7 · ADTV ₹55.0 cr · price-only.

Trend

Sales and net profit by fiscal year, ₹ crore

Not in the Buoyant book: no house thesis or target is carried. Exchange masters, Tijori and the reference price feed as stated on each tab. All listed companies · NSE EQ